CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

BACKGROUND: To validate the utility of the chemokine ligand 12 (CXCL12) as prognostic marker in patients with localized and metastatic germ cell tumors (GCT). METHODS: CXCL12 expression was analyzed on a tissue microarray consisting of 750 tissue cores of different histological tumor components, Ger...

Descripción completa

Detalles Bibliográficos
Autores principales: Fankhauser, Christian Daniel, Roth, Lisa, Grossmann, Nico Christian, Kranzbühler, Benedikt, Eberli, Daniel, Sulser, Tullio, Moch, Holger, Bode, Peter-Karl, Beyer, Joerg, Hermanns, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693197/
https://www.ncbi.nlm.nih.gov/pubmed/31412792
http://dx.doi.org/10.1186/s12885-019-5961-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693197/
https://www.ncbi.nlm.nih.gov/pubmed/31412792
http://dx.doi.org/10.1186/s12885-019-5961-1

Ejemplares similares